Table 3.
Clinical |
Routine HIV screening in cancer centers. |
Systematic and aggressive cancer screening of HIV-infected patients. |
Improvement of cancer prevention capabilities and access to cancer treatment for HIV-infected patients. |
Early detection and treatment of coinfections caused by carcinogenic viruses (eg, hepatitis B virus, hepatitis C virus, and human papillomavirus) in cancer patients with HIV. |
Research |
Inclusion of HIV-infected cancer patients in clinical trials of both cancer drugs and ART. |
Characterization of drug interactions between ARTs and chemotherapy agents, including newer agents. |
Well-designed studies of antimicrobial prophylaxis. |
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus.